Hospital News and Research

RSS

Ingenix TrendView solution helps companies better understand, manage employee medical costs

Ingenix is launching Ingenix TrendView, an affordable, easy-to-use desktop solution designed to help companies better understand and manage a critical expense category - employee medical costs. Ingenix TrendView provides graphical views of consolidated employee benefits usage, enables scenario modeling, and uncovers opportunities for reducing medical costs and improving employee health.

20 May 2010

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions, Inc., announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate update.

20 May 2010

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

Antigenics today announced that data from a multi-center Phase 1/2 clinical trial of Oncophage (vitespen) for recurrent high-grade glioma (brain cancer) was presented at the International Conference on Brain Tumor Research and Therapy. The study was conducted by the Brain Tumor Research Center at the University of California, San Francisco.

20 May 2010

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

Elsevier/MC Strategies, a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the American Association of Critical-Care Nurses (AACN) to develop a series of online nursing courses. Today, AACN and Elsevier/MC Strategies announced the first course in this series: AACN Critical Care Pharmacology.

20 May 2010

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

A popular belief that specific dietary changes can improve the symptoms of children with autism was not supported by a tightly controlled University of Rochester study, which found that eliminating gluten and casein from the diets of children with autism had no impact on their behavior, sleep or bowel patterns.

20 May 2010

Spanish researchers reprogram adult stem cells to help cardiac muscle regeneration

Spanish researchers have employed for the first time adult cells extracted from a human heart to turn stem cells from adipose tissue into cardiac myocytes. In other words, they achieved to "reprogram" adult stem cells, which might improve treatments for heart disease therapeutical.

20 May 2010

American Legion testifies in Congress on bills affecting veterans

The American Legion testified in Congress yesterday on several pieces of pending legislation that would affect veterans if signed into law.

20 May 2010

Grifols reaches agreement with Pharmalink to acquire PPS drug development project

Today, Grifols SA announced that it has reached an agreement with the Swedish company Pharmalink AB to acquire various forms of intellectual property associated with the treatment of post-polio syndrome. The acquisition is expected to be finalized in the next few weeks and will include documentation, know-how, and Swedish regulatory approvals under the trade name Xepol.

20 May 2010

Canadian Cancer Society advocates for greater access to quality palliative care

Cancer is the leading cause of death in Canada, making end-of-life care a growing concern as the population ages. This year's annual Canadian Cancer Statistics report, released by the Canadian Cancer Society, highlights the often heartbreaking challenges faced by dying cancer patients and their friends and family members who often take on the role of caregivers.

20 May 2010

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

In non-sleepy patients with obstructive sleep apnea, treatment with continuous positive airway pressure can reduce the incidence of cardiovascular events and hypertension, according to researchers from Spain.

20 May 2010

Androgen receptors promote hepatitis B virus in growth and development of hepatoma cells

Dr. Ming-Heng Wu of the Institute of Basic Medical Sciences at National Cheng Kung University (NCKU), Taiwan, in collaboration with Prof. Chawnshang Chang's laboratory of University of Rochester (UR), United States, have discovered that androgen receptors (AR) can promote hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus (HBV) RNA transcription.

20 May 2010

Treatment costs higher for CVD patients readmitted after leaving hospitals against medical advice

A University of Maryland School of Pharmacy study shows that among patients with cardiovascular disease (CVD) who discharged themselves from the hospital early the treatment cost if they are readmitted runs 9 percent higher compared to CVD patients who had been formally discharged.

20 May 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes. And, according to a recent study, they can find relief for both their symptoms and their wallets, saving anywhere from $50 to $400 in out-of-pocket costs per visit if they skip the emergency room and head to urgent care and retail health clinics when they are unable to see their primary physician.

20 May 2010

Expert 'top tips' for management of childhood eczema

Several leading European dermatologists have launched guidance to help parents reduce the burden of eczema on children living with this disease. Experts from Denmark, France, Germany, Poland and Spain have come together to agree a consensus of 'top tips', which focus on avoiding situations that trigger painful flares and different ways to increase eczema 'flare-free' periods. The 'top tips', sponsored by Astellas Pharma Europe Ltd., are launched at the 10th European Society for Pediatric Dermatology Congress (ESPD), Switzerland.

20 May 2010

Recruitment of children and adults with type 1 diabetes commences in Protege Encore teplizumab trial

Dr. Barry Reiner announced that he is now recruiting children and adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.

20 May 2010

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

Studies have well established that women who harbor a mutation in the BRCA1 tumor suppressor gene are at greater risk for developing breast and ovarian cancers. Less known is information on other molecular events that may impact cancer formation in cells having a BRCA1 mutation. Investigators from The Cancer Institute of New Jersey and a number of major cancer centers in Europe have identified the role a key protein plays in helping cells with mutant BRCA1 genes to survive.

20 May 2010

Update on Phase I clinical trials of Oncopore for treatment of cancer

The Norwegian pharmaceutical company Lytix Biopharma AS provided an update at the recent BIO conference in Chicago on Phase I clinical trials of Oncopore (LTX-315) for the treatment of cancer.

20 May 2010

Illusion challenges human visual system and brain

A new amazing illusion proves that defying gravity may be as simple as your point of view.

20 May 2010

Adult, pediatric critical care and progressive care units named recipients of 2010 Beacon Award for Excellence

The American Association of Critical-Care Nurses recently named 73 units — including 60 adult, four pediatric critical care and nine progressive care units — nationwide recipients of the spring 2010 Beacon Award for Excellence.

20 May 2010

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Trius Therapeutics, Inc. today announced that it has been awarded a new four and a half year contract from the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, for the development of novel antibiotics directed against gram-negative bacterial pathogens. Trius may receive up to $29.5 million in support of development efforts under the new DTRA contract, which is funded as part of DTRA's Transformational Medical Technologies Initiative (TMTI).

20 May 2010

Hospital News and Research

Ingenix TrendView solution helps companies better understand, manage employee medical costs

BioLife Solutions first-quarter revenue up 36% to $513,000

Phase 1/2 clinical trial data of Oncophage for recurrent high-grade glioma

AACN and Elsevier/MC Strategies announce Critical Care Pharmacology online nursing course

GFCF diet shows no significant benefits on the behavior of children with ASD: Study

Spanish researchers reprogram adult stem cells to help cardiac muscle regeneration

American Legion testifies in Congress on bills affecting veterans

Grifols reaches agreement with Pharmalink to acquire PPS drug development project

Canadian Cancer Society advocates for greater access to quality palliative care

Studies show positive effects of CPAP on cardiovascular incidence in non-sleepy OSA patients

Androgen receptors promote hepatitis B virus in growth and development of hepatoma cells

Treatment costs higher for CVD patients readmitted after leaving hospitals against medical advice

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

Expert 'top tips' for management of childhood eczema

Recruitment of children and adults with type 1 diabetes commences in Protege Encore teplizumab trial

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

Update on Phase I clinical trials of Oncopore for treatment of cancer

Illusion challenges human visual system and brain

Adult, pediatric critical care and progressive care units named recipients of 2010 Beacon Award for Excellence

Trius awarded new DTRA contract for developing novel antibiotics against gram-negative bacterial pathogens

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News